VentriPoint Diagnostics Ltd (VPTDF)

[teq0904]

Here’s what George had to say in his follow up email today
> Attached is a news release about a group of doctors in The Netherlands, who have been using the VMS to study patients with Sarcoidosis - a disease that mostly affects the lungs and puts people at risk for pulmonary hypertension.
>
> The study will be published in a top peer-reviewed medical journal later this year, but the investigators have given us permission to release these top-line results.
>
> 1. 20 of the 500 patients had abnormal RV shapes and pulmonary hypertension, which as you know is a very serious condition and needs to be detected early for any hope of treatment.
> 2. This is the first study showing the VMS can be used to “screen" people at risk for pulmonary hypertension and find those people who have already developed the condition.
> 3. There are lots of conditions that give rise to pulmonary hypertension (lung cancer, sickle-cell anemia, COPD, etc.) and so this is an exciting study.
> 4. Our marketing group has identified the doctors in Europe and North America who specialize in Sarcoidosis and will now begin a campaign to make them aware of the VMS’s ability to screen their patients.
> 5. The guidelines suggest that patients should be screened every three months for signs of pulmonary hypertension, but this has been impossible as the only way to diagnose pulmonary hypertension is by cardiac catheterization, which is invasive and dangerous.
> 6. We applaud this group in the The Netherlands for such an innovative clinical study and await even more information on the ability of the VMS to monitor the progression for he disease in these patients.